Screener
Solid Biosciences Inc. SLDB Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s free cash flow?
- Solid Biosciences Inc. (SLDB) reported free cash flow of -$52.74M in Q2 2026.
- How has Solid Biosciences Inc.'s free cash flow changed year-over-year?
- Solid Biosciences Inc.'s free cash flow decreased by 39.6% year-over-year, from -$37.79M to -$52.74M.
- What is the long-term trend for Solid Biosciences Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s free cash flow has grown at a 18.8% compound annual growth rate (CAGR), from -$79.05M to -$157.44M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Solid Biosciences Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude